HomeGeneticsConditionGlutaric acidemia type II
Back to Condition
Glutaric acidemia type II
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Glutaric acidemia type II

Glutaric acidemia type II is a rare inherited metabolic disorder that prevents the body from properly breaking down proteins and fats, leading to dangerous acid buildup and life-threatening metabolic crises.

Overview

Glutaric acidemia type II is an inherited disorder that interferes with the body's ability to break down proteins and fats to produce energy. When these nutrients are incompletely processed, they accumulate in the body and cause the blood and tissues to become dangerously acidic, a condition known as metabolic acidosis.

Symptoms and Clinical Features

The signs and symptoms of glutaric acidemia type II vary widely in severity and can appear at different stages of life.

Metabolic Crisis

In infancy or early childhood, the disorder typically presents as a sudden, life-threatening episode called a metabolic crisis. These crises can be triggered by common childhood illnesses or other physical stresses. Symptoms include:

  • Acidosis
  • Low blood glucose (hypoglycemia)
  • Weakness
  • Vomiting
  • Behavioral changes, such as poor feeding and decreased activity

Severe Physical Abnormalities

In the most severe cases, affected individuals may be born with physical malformations, which can include:

  • Brain malformations
  • An enlarged liver (hepatomegaly)
  • A weakened and enlarged heart (dilated cardiomyopathy)
  • Fluid-filled cysts and other malformations of the kidneys
  • Unusual facial features and genital abnormalities
  • A characteristic body odor resembling sweaty feet

Mild and Late-Onset Forms

Some individuals experience milder forms of the disorder that begin later in childhood or during adulthood. In the mildest cases, the first sign of the condition may be muscle weakness that develops in adulthood.

Frequency

Glutaric acidemia type II is a very rare disorder. Its precise incidence is unknown, though it has been reported across several different ethnic groups.

Causes & Genetic Factors

Mutations in any of three genes—ETFA, ETFB, or ETFDH—can cause glutaric acidemia type II:

  • The ETFA and ETFB genes provide instructions for making the subunits of an enzyme called electron transfer flavoprotein.
  • The ETFDH gene provides instructions for making an enzyme called electron transfer flavoprotein dehydrogenase.

Both enzymes are active in the mitochondria, the energy-producing centers of cells, where they help break down proteins and fats. A deficiency in either enzyme causes partially broken down nutrients to accumulate and damage cells. Mutations that result in a complete loss of either enzyme lead to the most severe symptoms, while mutations that allow the enzymes to retain some activity result in milder forms of the disorder.

Inheritance

This condition is inherited in an autosomal recessive pattern. This means both copies of the gene in each cell must have mutations for the individual to be affected. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Other Names for This Condition

    Frequently Asked Questions

    metabolic crisis often presents with sudden vomiting, lethargy, weakness, low blood sugar, and rapid breathing. If you notice these signs, call emergency services right away. Bring the child to the nearest hospital and inform the staff that the patient has glutaric acidemia type II; this alerts them to monitor blood pH, glucose, and electrolytes closely and to start intravenous fluids and bicarbonate therapy as directed by the metabolic team.
    Glutaric acidemia type II is inherited in an autosomal recessive manner. If both parents carry a pathogenic variant, each pregnancy has a 25 % chance of producing an affected child. Genetic counseling can provide carrier testing for family members, discuss pre‑implantation genetic diagnosis (PGD) or prenatal testing options, and explain the implications of different mutation types on disease severity.
    Patients typically need a low‑protein diet with reduced intake of long‑chain fatty acids. A dietitian will prescribe a specific protein allowance (often 0.8–1.0 g/kg/day) and recommend medium‑chain triglyceride (MCT) supplements to provide energy without causing acid accumulation. Use a food diary, weigh portions, and check the label for protein content. Regular blood tests for ammonia, lactate, and acylcarnitine profiles help confirm adherence.
    Supplementation with carnitine (usually 100–200 mg/kg/day) can improve fatty acid oxidation and reduce acid buildup. Some patients benefit from riboflavin (vitamin B2) or biotin, especially if a specific enzyme deficiency is identified. Antioxidants like vitamin E may also be prescribed. Always discuss dosing with the metabolic specialist before starting any new supplement.
    Source: MedlinePlus, National Library of Medicine

    MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

    Meyahealth

    Ⓒ 2026. All rights reserved by MEYA